logo
Select company
Select metric
$ 6.91MNet Cash Flow - Investing
VS
Market
85
Sector
76
Industry
69
History
100
$ 2.48Close
$ 1.1 - $ 5.94 52-Week Range
Ticker Information

Ticker

TCRX

Company Name

TSCAN THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

TSCAN THERAPEUTICS INC - Net Cash Flow - Investing Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

TCRX - CF - Investing Historical data
DateNet Cash Flow - Investing
6/30/2025$ 6.91M
3/31/2025$ -75.25M
12/31/2024$ -52.61M
9/30/2024$ -77.99M
6/30/2024$ -57.05M
3/31/2024$ -23.76M
12/31/2023$ -60.76M
9/30/2023$ -64.05M
6/30/2023$ -3.06M
3/31/2023$ -4.53M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • TSCAN THERAPEUTICS INC's latest trailing twelve months (TTM) CF - Investing stands at $ -4.24M.
  • Over the past 5 years, TSCAN THERAPEUTICS INC's average CF - Investing has been $ -28.04M.
  • The median CF - Investing for TSCAN THERAPEUTICS INC during this period was $ -8.73M
  • TSCAN THERAPEUTICS INC reached its highest CF - Investing over the past 5 years at $ 6.91M.
  • The lowest CF - Investing recorded by TSCAN THERAPEUTICS INC in the same timeframe $ -77.99M

TSCAN THERAPEUTICS INC's CF - Investing vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

CF - Investing Benchmarks
CompanyCF - Investing
CRVO : CERVOMED INC $ 17.05MFATE : FATE THERAPEUTICS INC $ 110.54MOVID : OVID THERAPEUTICS INC $ 38.74MARMP : ARMATA PHARMACEUTICALS INC $ -511KCBUS : CIBUS INC $ -795KCUE : CUE BIOPHARMA INC $ -80KVERU : VERU INC $ 19MSRZN : SURROZEN INC $ -64KPSTV : PLUS THERAPEUTICS INC $ -1.02MKRRO : KORRO BIO INC $ 6.14M

Definition of Net Cash Flow - Investing

[Cash Flow Statement] The amount of cash inflow (outflow) from investing activities. Investing actives include disposal (expenditure) of capital assets [CapEx], sale (purchase) of business [NCFBus] and of investments [NCFInv].

TCRX - Net Cash Flow - Investing, Last 5 years

$ -77.99M

Minimum

Sep 30, 2024

$ 6.91M

Maximum

Jun 30, 2025

$ -28.04M

Average

$ -8.73M

Median

CF - Investing Benchmark Analysis

The chart above depicts the distribution of CF - Investing for companies in the Total Stock Market. The average CF - Investing of the companies is $ -35.29M with a standard deviation of $ 83.34M.
The following table provides additional summary stats:
CF - Investing in the Market:
filtered constituents3.17K
min$ -292.23M
max$ 241M
average$ -35.29M
median$ -6.38M
std$ 83.34M